TL;DR — The American College of Physicians (ACP) Internal Medicine Meeting 2026 runs in April 2026 at the Moscone Center in San Francisco. Standard registration lands at $725 for members, $1,175 for the premium member tier (pre-courses, simulation, on-demand access), and $1,386 for non-members. Early-bird rates discount each tier in the months before the meeting. Attendance runs 7,000-10,000 — overwhelmingly practicing internists, primary care physicians, and internal medicine subspecialists — making ACP the single highest-density U.S. touchpoint for adult medicine prescribing and referral behavior. For medical device, pharma, and digital health brands, ACP rewards pre-booked physician meetings, evidence-led booth content, and a follow-up cadence built around real prescribing and referral timelines, not generic post-show drip.

What ACP Is — and Why San Francisco 2026 Matters

The American College of Physicians is the largest medical specialty organization in the United States, representing more than 160,000 internal medicine physicians, subspecialists, residents, fellows, and medical students. Internists are the engine of adult primary care and a substantial share of inpatient adult medicine. They are also the cohort that prescribes the bulk of chronic disease therapies, orders the bulk of cardiometabolic diagnostics, and refers patients into virtually every internal medicine subspecialty and surgical subspecialty downstream. There is no other annual meeting in the U.S. that brings this audience together at this scale.

ACP Internal Medicine Meeting 2026 lands in San Francisco at Moscone Center in April. San Francisco is a strong draw for ACP — the city consistently produces above-average attendance versus smaller-market years, and Moscone's exhibit hall and education space support the meeting's hybrid format of large-room plenaries, multi-track clinical updates, hands-on simulation, and a substantial exhibit floor. Early-spring timing places ACP at the front end of the calendar-year prescribing and procurement cycle, when health systems, group practices, and individual internists are reassessing formularies, point-of-care platforms, and clinical workflow tools after Q1.

For exhibitors and educational sponsors, San Francisco 2026 is a high-leverage opportunity. The Bay Area concentration of digital health, point-of-care diagnostics, and chronic disease platforms means many companies have local headquarters or anchor offices within minutes of Moscone, which simplifies on-site logistics and post-show physician visits. The flip side is competitive intensity — every adjacent meeting and dinner program in the city is competing for the same internist attention during ACP week. The vendors who win are the ones who plan three months out.

ACP 2026 Registration Rates: Standard, Premium, and Non-Member

The math between tiers is worth thinking through carefully. A non-member paying $1,386 is paying $661 more than a member at the $725 standard rate. ACP membership annual dues are well below that differential for fully credentialed internists, which means most non-member attendees are leaving money on the table by not joining ACP first and registering at the member rate. For program directors, divisions, and group practices sending multiple physicians, the membership conversion is even more obvious.

The $1,175 premium member tier sits in a different decision frame. The premium add-on buys pre-courses (typically deep-dive half-day or full-day sessions on a single clinical topic), simulation center access, and a 12-month on-demand library of recorded sessions. For physicians who plan to claim 30+ CME credits at ACP, who want simulation lab time on procedural skills, or who genuinely use on-demand review through the year, the $450 premium uplift pays back. For attendees whose ACP plan is core didactic sessions plus exhibit hall, the $725 standard member rate is usually the right call. Most ACP attendees should make the standard-versus-premium decision deliberately rather than defaulting to either.

One nuance for exhibitors and pharma brands: physician registration cost is part of the meeting's perceived value. Higher rates mean attendees arrive expecting clinical depth and credible education. Booth experiences that feel like consumer-grade marketing fall flat against that expectation. Lead with peer-reviewed evidence, real-world outcomes data, and clinical specialists — not with sales reps and giveaway tables.

The ACP 2026 Audience: Who Actually Walks the Floor

ACP 2026 will draw 7,000-10,000 attendees in San Francisco, with the mix weighted toward practicing physicians rather than academics. The breakdown that matters for vendors:

For medical device and pharma brands, the strategic insight is that ACP is not a single-audience meeting. The booth strategy that converts general internists is different from the strategy that converts cardiology subspecialists, and both are different from what works with residents and fellows. Treat ACP as three or four parallel audiences within one floor, and tier your messaging, demos, and follow-up accordingly. Our marketing to primary care physicians guide covers the segmentation logic in more depth.

Pre-Conference Strategy: Booking Internist Meetings Before You Land

ACP is too big to win on walk-up traffic alone. Internists do not wander the exhibit hall the way fellows or residents do — they have specific clinical updates to attend, specific colleagues to meet, and a tight CME-driven schedule that leaves limited unstructured floor time. The vendors who consistently produce post-show pipeline at ACP do their meeting-booking work eight to twelve weeks before the meeting opens.

Build a named target physician list by February. Start with every internist, primary care physician, or subspecialist you have ever sold into or detailed. Layer in the top 50-100 internal medicine residency programs in your target geographies, the top 100 large primary care groups and IPAs, the medical directors of relevant ACOs and value-based care organizations, and the chairs and division chiefs of academic internal medicine programs you want to influence. Aim for a named target list of 150-300 physicians with the specific clinical questions, formulary decisions, and protocol updates each one is working through in 2026.

Run a multi-channel pre-show outreach sequence. Email is the workhorse, but ACP-attending internists respond to a layered cadence: a clinically substantive email referencing a recent publication or guideline update, a LinkedIn connection from a clinical specialist (not a sales rep), a peer-reviewed evidence drop tied to your category, a specific San Francisco meeting slot, and a pre-show confirmation. Our pre-conference email campaigns guide walks through subject lines, timing, and content patterns that work at ACP scale. Pair that with targeted display and content advertising inside the ACP ecosystem and adjacent internal medicine journals in the eight weeks before the meeting.

Sponsor or align with ACP-credible education. Independent CME, satellite symposia adjacent to ACP, and ACP-aligned content partnerships build floor traffic that pure sponsorship cannot. Internists are evidence-driven and faculty-driven — the booths that draw them are the ones connected to clinical updates and respected faculty they already trust. If your brand has a story that maps to a 2026 guideline update or a recent landmark trial, design the pre-show content arc around that story, not around the product page.

Booth and Content Strategy for the ACP Floor

ACP attendees are clinically sophisticated and time-constrained. Booth design that works for them is fundamentally different from a consumer health or specialty surgical meeting. Win the Moscone floor by treating the audience like the prescribers and referrers they are.

Lead with clinical evidence, not features. Static graphics should answer the four questions every internist asks within 30 seconds of approaching a booth: What is the clinical evidence and how recent is it? Which guidelines and societies have endorsed the product or approach? What is the real-world safety and effectiveness profile? How does this integrate into a typical internist workflow and what is the reimbursement story? Generic claims fall flat. Specific peer-reviewed citations with n-values, registry data, and named guideline references win attention.

Structure the booth as a clinical conversation, not a transaction. Internists do not want a 90-second pitch from a generalist sales rep. They want a 5-10 minute clinical conversation with someone who can speak credibly about the disease state, the evidence base, and the workflow trade-offs. Staff the booth with medical affairs, clinical specialists, and senior physicians as the front line, with sales support behind them rather than in front of them. For a tightly defined audience like ACP, the staffing mix is more determinative of outcomes than booth size or build quality.

Build for downstream referral patterns where they exist. Many ACP attendees are the front door of adult medicine even when they are not the end prescriber or implanter. A cardiac device, a GI diagnostic, an endocrinology therapeutic, or a chronic disease management platform often gets ordered because an internist made the referral that put the patient in front of the specialist. Booth messaging that helps the internist understand when, how, and to whom to refer often produces more downstream volume than messaging aimed at the eventual prescriber. Our medical conference booth design playbook covers zone layouts and signage hierarchy that hold up for this audience.

On-Site Tactics: Symposia, Dinner Programs, and Real Conversations

ACP is a meeting where the highest-value commercial activity often happens off the exhibit floor. Independent satellite symposia, fee-for-service speaker programs, KOL dinners, and small-format clinical conversations consistently produce more post-show prescribing and referral lift than booth traffic alone. The companies that win ACP build a full week of activity, with the booth as the daytime anchor and curated evening programs as the relationship layer.

Satellite symposia and CME-accredited education. A well-designed satellite symposium with respected ACP-aligned faculty, scheduled in the hour before or after a high-traffic ACP clinical update, can pull 200-400 attendees who are exactly the audience your brand wants in front of. Independent CME accreditation matters here — internists are sophisticated about commercial bias and will discount content that feels like a product pitch dressed up as education.

KOL dinners and small-format clinical conversations. A 12-20 person dinner with two or three ACP-aligned KOLs, a tight clinical agenda, and a structured Q&A consistently produces more relationship value per dollar than equivalent booth investment. The audience size is the feature, not the bug — internists who would never have stopped at your booth in an exhibit hall will go deep on the clinical questions over a structured dinner conversation.

Scheduled booth meetings with target physicians. The booth is most valuable as a meeting venue when you have pre-booked target internists and subspecialists for specific time slots. Block calendar windows for these conversations and protect them from walk-up interruption. A tiered approach works: Tier 1 target-list physicians get same-day calendar invites for in-San-Francisco dinners or clinical specialist calls; Tier 2 high-value walk-up leads get structured nurture sequences with evidence content; Tier 3 residents, fellows, and medical students get long-cycle nurture aimed at the three-to-five-year horizon when they enter independent practice and start making first-time prescribing decisions.

Post-ACP Follow-Up: Converting Internist Pipeline

The most common post-ACP mistake is treating every booth lead as a single timeline. A practicing internist who told your team they want to evaluate your point-of-care diagnostic for diabetes screening needs a different follow-up cadence than a residency program director evaluating a curriculum partnership, a health system value analysis committee member assessing a digital health platform, or a subspecialist KOL who attended your dinner program. Internist prescribing decisions can convert in 30-90 days for well-positioned products. Health system formulary and capital decisions run 6-18 months. Curriculum and academic partnerships run 12+ months.

Build the post-ACP cadence around the buyer, not the lead source. Same-week personalized outreach from the clinical specialist who had the on-site conversation. A 30-day follow-up with a peer-reviewed evidence drop or a recorded clinical conversation. A 60-day follow-up with a peer reference physician using the product in similar volume and patient mix. A 90-day touchpoint with a category-specific update — a new guideline, a new trial, a new real-world dataset. Our post-conference follow-up playbook covers the CRM workflow and segmentation rules that hold up across these timelines.

Treat the resident and fellow cohort as a separate, long-cycle nurture track. Today's internal medicine senior resident is making first-time independent prescribing and referral decisions in 12-24 months. The vendors who build relationships with residents at ACP — through educational content, mentorship-style touchpoints, and respect for the long horizon — compound their investment for years. Most brands ignore residents entirely. The ones who do not own the next decade of prescribing behavior in internal medicine.

Should Your Brand Exhibit at ACP 2026?

Yes, if your audience includes general internists, primary care physicians, or any internal medicine subspecialty whose prescribing or referral behavior matters to your business. The categories that consistently see strong ACP ROI include cardiometabolic therapeutics and devices, diabetes management technology, GLP-1 and cardiometabolic comparator programs, point-of-care diagnostics, chronic disease management platforms, digital health and remote patient monitoring, hypertension and lipid management therapeutics, GI diagnostics and therapeutics with internist-driven referral patterns, infectious disease therapeutics, mental health platforms designed for primary care, and any product whose adoption depends on internist endorsement or referral. Pair ACP with a disciplined conference marketing ROI framework and the math clears comfortably for most brands serving this audience.

No, if your audience is exclusively pediatric, surgical, or radically subspecialty without internist touchpoints. There are better-fit meetings for those audiences. ACP is an adult medicine meeting, and the floor traffic will not produce qualified pipeline for products that do not interact with internist prescribing, referral, or care management behavior.

For most brands serving adult medicine, ACP belongs on the calendar as a tier-one annual investment, not a discretionary one. The audience density is unmatched, the cost-per-qualified-prescriber math is strong, and the relationship value compounds over multi-year presence. The vendors who treat ACP as a single annual touchpoint underperform the ones who treat it as the anchor of a 12-month internal medicine engagement strategy. For broader context on adult medicine marketing, see our primary care physician marketing guide and medical device marketing services.